新闻中心
NEWS CENTER
Deepen Exchanges to Forge New Prospects, Join Hands for Mutual Success——Chairman of Neostar United Group and his delegation visited Yangtze River Pharmaceutical Group for inspection and exchange
Release time:
2026-05-27
On May 25, 2026, Mr. Cao, Chairman of Neostar United Group, led the core management team on an on-site visit to Zilong Pharmaceutical, a subsidiary of Yangtze River Pharmaceutical Group, for an in-depth exchange and discussions.
To further strengthen the cooperation foundation with industry leaders and promote the in-depth development of bilateral business synergy, on May 25, 2026, Mr. Cao, Chairman of Neostar United Group, led the core management team on an on-site visit to Zilong Pharmaceutical, a subsidiary of Yangtze River Pharmaceutical Group, for an in-depth exchange and discussions. The two parties engaged in practical communication on topics such as deepening existing business cooperation and expanding new scenarios for industrial synergy, injecting new momentum into the subsequent upgrading of their collaboration.
On-site Visit: Tracing the Benchmark Strength and Defining the Direction of Cooperation
Accompanied by the relevant responsible persons of Zilong Pharmaceutical, the Neostar United team visited the company's product exhibition area, production monitoring center, and small-volume injection production workshop in succession, systematically gaining a comprehensive understanding of Zilong Pharmaceutical's development history, core product portfolio, whole-process quality control system, and intelligent production and operational model.
During the visit, the two parties engaged in detailed discussions focusing on optimizing production processes, upgrading quality standards, and enhancing supply chain coordination efficiency for their existing collaborative products. At the same time, based on Zilong Pharmaceutical’s new product pipeline and Neostar United Group’s advantages in channel resources, they conducted preliminary explorations into potential future cooperation directions. From the iterative upgrades of self-developed products displayed in showcases to the real-time visualization of standardized production workflows on monitoring screens, the Neostar United team gained a tangible understanding of Yangtze River Pharmaceutical Group's corporate philosophy of "Protecting All Living Beings" and its core strengths across pharmaceutical R&D, manufacturing, and quality control—providing clear guidance for expanding future cooperation opportunities.
Exchange Meeting: Focusing on Upgrading Cooperation, Exploring New Chapters of Synergy
Subsequently, the two teams engaged in in-depth discussions and exchanges. The relevant representative of Zilong Pharmaceutical extended a warm welcome to the delegation from Neostar United and highly commended the achievements of their previous collaboration. He noted that Neostar United's professional foreign trade channels and industrial service capabilities have provided strong support for Yangtze River Pharmaceutical's market expansion; he expressed hope that this exchange would serve as an opportunity for both parties to further explore multi-dimensional cooperation models—including joint product development, co-built marketing channels, and collaborative supply chain optimization—building on their existing business relationships to achieve complementary strengths and mutual empowerment.
Focusing Resources for Mutual Success: Promoting Upgrades through Deep Engagement and Creating the Future through Collaboration
This inspection and exchange visit not only served as an important opportunity for Neostar United and Zilong Pharmaceutical (a subsidiary of Yangtze River Pharmaceutical Group) to deepen their existing collaboration and expand synergistic prospects, but also further strengthened mutual trust and consensus between the two parties, injecting strong momentum into the extension of future collaboration toward deeper levels and broader fields.
In the future, Neostar United Group will continue to uphold the principles of open cooperation and collaborative development. Anchored by existing business partnerships, Neostar United Group will actively promote the upgrading of cooperation with Yangtze River Pharmaceutical Group, achieving mutual benefits through resource sharing and complementary advantages. Simultaneously, Neostar United Group will deepen its focus on the pharmaceutical industry sector, enhance exchanges and interactions with leading enterprises in the field, continuously strengthen its core competitiveness, and contribute to promoting high-quality development within the pharmaceutical industry.
Previous Page
Recommend News
+0086-519-85551759
Tel: +0086-519-85556579
Fax: +0086-519-85557389
E-mail: info@neostarunited.com
Add: Building 5, No.2188 Longcheng Avenue,
Zhonglou District, Changzhou, Jiangsu, China